Herb-drug interactions: Interactions between Ginkgo biloba and prescription medications

Geriatrics

Volumn 60, Issue 4, 2005, Pages 30-33

  Bressler, Rubin ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Complementary and alternative medicines; Ginkgo biloba; Herbal interactions

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; GINKGO BILOBA EXTRACT; GLYCOPROTEIN P; HALOPERIDOL; IBUPROFEN; NIFEDIPINE; OMEPRAZOLE; TRAZODONE; WARFARIN;

AEROBIC METABOLISM; AGING; ALERTNESS; ALTERNATIVE MEDICINE; AMNESIA; ANXIETY DISORDER; ASTHMA; BLEEDING; BRAIN DYSFUNCTION; CLONIC SEIZURE; DEMENTIA; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; ENZYME INDUCTION; ENZYME MECHANISM; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HEADACHE; HEALTH STATUS; HEART PALPITATION; HERBAL MEDICINE; HUMAN; INTERMITTENT CLAUDICATION; KIDNEY METABOLISM; LETHALITY; LIVER METABOLISM; LONG TERM CARE; LUNG; NEUROPROTECTION; PATIENT INFORMATION; PRESCRIPTION; RAYNAUD PHENOMENON; REVIEW; SEDATION; SHORT TERM MEMORY; SIDE EFFECT; SKIN MANIFESTATION; SKIN TOXICITY; SUBDURAL HEMATOMA; THROMBOSIS; TINNITUS; TONIC SEIZURE; UNCONSCIOUSNESS; URINARY EXCRETION;

AGED; COMPLEMENTARY THERAPIES; GINKGO BILOBA; HERB-DRUG INTERACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG;

EID: 17244363545     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Ang-Lee MK, Moss MK, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286(2):208-16.
2. Ernst E, Pittler MH. Herbal medicine. Med Clin North Am 2002; 86(1):149-61.
3. Astin, JA. Why patients use alternative medicine: Results of a national study. JAMA 1998: 279(19):1548-53.
4. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328(4)246-52.
5. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003: 78(12):1564-77.
6. Ernst, Edzard. The risk-benefit profile of commonly used herbal therapies: Gingko, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002; 136(1):42-53.
7. Miller LG. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998; 158(20):2200-11.
8. Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs and aging 2001; 18(11):837-51.
9. Klotz U. Effect of age on pharmacokinetics and pharmacodynamics in man. Int J Clin Pharmacol Ther 1998; 36(11):581-5.
10. th ed. New York, NY: McGraw-Hill Book Co.; 2001:3-29.
11. Okey AB. Enzyme induction in the cytochrome P450 system. Pharmacol Ther 1990; 45(2):241-98.
12. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31(2):155-63.
13. nd ed. Washington, DC: American Psychiatric Publishing;2003:11-40.
14. David S. Tatro, ed. Drug Interaction Facts: Herbal Supplements and Food. Saint Louis, MO; Facts and Comparisons, A. Walters Kluwer Company; 2004. Also available online at: www.factsandcomparisons.com.
15. Kleijnan J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992; 34(4):352-8.
16. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998; 55(11):1409-15.
17. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a met-analysis of randomized trials. Am J Med 2000; 108(4):276-81.